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Following publication of the original article [1], it has 
been brought to our attention that an incorrect Seque-
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were used to represent the PIK3CA p.E545A mutation in 
Fig. 2b. The correct Fig. 2b is shown in this erratum. The 
authors apologize for the confusion.
Page 2 of 2Fassan et al. Cancer Cell Int          (2019) 19:244 
Author details
1 Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), 
University of Padua, via Gabelli 61, 35121 Padua, Italy. 2 Department of Surgical 
Oncology and Gastroenterology (DiSCOG), University of Padua, Padua, PD, 
Italy. 3 Unit of Oncology 1, Department of Clinical and Experimental Oncology, 
Istituto Oncologico Veneto, IOV-IRCCS, Padua, PD, Italy. 4 Division of Molecular 
Pathology, The Institute of Cancer Research, Sutton, London, UK. 5 Department 
of Medicine, The Royal Marsden NHS Trust, Sutton, London, UK. 6 Nanoin-
spired Biomedicine Laboratory, Institute of Pediatric Research, Fondazione 
Città della Speranza, Padua, PD, Italy. 7 Department of Nanomedicine, The 
Methodist Hospital Research Institute, Houston, TX, USA. 8 National Research 
Council, Neuroscience Institute, Aging Branch, Padua, PD, Italy. 9 Department 
of Diagnostics and Public Health, Section of Pathology, University and Hospital 
Trust of Verona, Verona, VR, Italy. 10 Veneto Cancer Registry, Padua, PD, Italy. 
11 National Institute of Gastroenterology-Research Hospital, IRCCS “S. de Bellis”, 
70013 Castellana Grotte, BA, Italy. 
Reference
 1. Fassan M, Vianello L, Sacchi D, Fanelli GN, Munari G, Scarpa M, Cappel-
lesso R, Loupakis F, Lanza C, Salmaso R, Mescoli C, Valeri N, Agostini M, 
D’Angelo E, Lonardi S, Pucciarelli S, Veronese N, Luchini C, Rugge M. 
Assessment of intratumor immune-microenvironment in colorectal 
cancers with extranodal extension of nodal metastases. Cancer Cell Int. 
2018;18:131. https ://doi.org/10.1186/s1293 5-018-0634-8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
BRAF c.1799T>A (p.V600E)






























































































































































Fig. 2 a Mutational profiling of the 15 cases profiled through a hotspot multigene mutational custom panel, including 164 hotspot regions of 
AKT1, APC, BRAF, CTNNB1, KIT, KRAS, NRAS, PDGFRA, PIK3CA, PTEN and TP53 genes. In red are the samples showing a different mutational landscape 
in comparison to the other matched samples (scale bars = 100 µm). b Representative Sequenom MassArray output profiles for KRAS c.436G> A 
(p.A146T), PIK3CA c.1634A>C (p.E545A), BRAF c1799T>A (p.V600E) and NRAS c.35G>A (p.G12D) mutations. On the right the correspondent Sanger 
chromatogram
The original article can be found online at https ://doi.org/10.1186/s1293 
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